medigraphic.com
ISSN 1561-3038 (Print)

2022, Number 1

<< Back Next >>

Rev Cubana Med Gen Integr 2022; 38 (1)

Clinical condition, functional capacity, anxiety or depression, and quality of life in patients with chronic obstructive pulmonary disease in different age groups

Betancourt-Peña J, Peñaranda-Ospina EV, Carvajal-Riascos AA, Ávila-Valencia JC, Benavides-Córdoba V

Language: Spanish
References: 30
Page: 1-16
PDF size: 575.91 Kb.


ABSTRACT

Introduction: Chronic obstructive pulmonary disease produces progressive disability in the person who presents the disease, because of frequent dyspnea, leading to limitations and restrictions in participation with age increase, which finally triggers anxiety and depression states secondary to their clinical condition.
Objective: To establish the differences in clinical condition, functional capacity, anxiety or depression, and quality of life in a group of patients between late adulthood, senescence and old age diagnosed with chronic obstructive pulmonary disease.
Methods: Descriptive study carried out in patients with chronic obstructive pulmonary disease, who were divided into age groups. Clinical variables were taken into account: functional capacity, anxiety or depression, and quality of life.
Results: Patients were distributed into age groups as follows: 45-59 years (old age), n=16; 60-79 years (senescence); n=89; and 80 years and older (old age); n=24. There were significant differences in the distance traveled, with the old age group presenting the worst result (235.25±106.8). Anxiety or depression did not show differences, and quality of life showed greater repercussion in the activity domain.
Conclusion: Patients in the late adulthood group presented better functional capacity compared to the senescence and old age groups. In turn, anxiety and depression were higher in patients in the late adulthood group; however, it was not significant between the groups.


REFERENCES

  1. Global Iniciative for Chronic Obstructive Lung Disease [GOLD]. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease; 2018.

  2. López-Varela MV, Muiño A, Pérez-Padilla R, Jardim JR, Tálamo C, Motes de Oca M, et al. Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO study. Arch Bronconeumol. 2008;44(2):58-64. DOI: https://doi.org/10.1016/S1579-2129(08)60016-6

  3. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. PREPOCOL. Prevalence of COPD in five Colombian cities situated at low, medium and high altitude. Chest. 2008;133(2):343-49. DOI: https://doi.org/10.1378/chest.07-1361

  4. De Lucas P, Grupo de trabajo de la SEPAR. Normativa sobre rehabilitación respiratoria. Arch Bronconeumol. 2000;36(5);257-74. DOI: https://doi.org/10.1016/S0300-2896(15)30167-8

  5. Zetina MG. Conceptualización del proceso de envejecimiento. Papeles de Población. Universidad Autónoma de México; 1999.

  6. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88. DOI: https://doi.org/10.1164/rccm.201908-1590ST

  7. 7.Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2013;187(4):382-6. DOI: https://doi.org/10.1164/rccm.201209-1596OC

  8. Betancourt-Peña J, Muñoz-Erazo BE, Mora-Guerra RV. Calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica al ingreso de un programa de rehabilitación pulmonar. Rev Col Reha. 2015;14(1):46-53. DOI: https://doi.org/10.30788/RevColReh.v14.n1.2015.18

  9. Paap MC, Brouwer D, Glas CA, Monninkhof EM, Forstreuter B, Pieterse ME, et al. The St George's Respiratory Questionnaire revisited: a psychometric evaluation. Qual Life Res. 2015;24(1):67-79. DOI: https://doi.org/10.1007/s11136-013-0570-y

  10. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 10th ed. Lippincott: Williams & Wilkins; 2017.

  11. World Medical Association (WMA) Declaration of Helsinki - Ethical principles for medical research involving human subjects. 2019 [acceso: 10/09/2021]. Disponible en: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human- subjects/#

  12. Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120(4):437-47. DOI: https://doi.org/10.1016/j.cell.2005.01.027

  13. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155-61. DOI: https://doi.org/10.1164/rccm.201201-0034OC

  14. Tantucci C, Modina D. Lung function decline in COPD. Int JChron Obstruct Pulmon Dis. 2012;7,95-9. DOI: https://dx.doi.org/10.2147/COPD.S27480

  15. Horner A, Soriano JB, Puhan MA, Studnicka M, Kaiser B, Vanfleteren LE, et al. Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir Res. 2017;18(1):162. DOI: https://doi.org/10.1186/s12931-017-0643-5

  16. Cortopassi F, Gurung P, Pinto-Plata V. Chronic obstructive pulmonary disease in elderly patients. Clin Geriatr Med. 2017;33(4):539-52. DOI: https://doi.org/10.1016/j.cger.2017.06.006

  17. Mizumura K, Maruoka S, Shimizu T, Gon Y. Autophagy, selective autophagy, and necroptosis in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3165-72. DOI: https://doi.org/10.2147/COPD.S175830

  18. Ades PA, Savage PD, Brawner CA, Lyon CE, Ehrman JK, Bunn JY, et al. Aerobic capacity in patients entering cardiac rehabilitation. Circulation. 2006;113(23):2706-12. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.606624

  19. Fleg JL, Morrell CH, Bos AG, Brant LJ, Talbot LA, Wright JG, et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation. 2005;112(5):674-82. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.545459

  20. Spruit MA, Franssen FM, Rutten E, Wagers SS, Wouters EF. Age-graded reductions in quadriceps muscle strength and peak aerobic capacity in COPD. Rev Bras Fisioter. 2012;16(2):148-56. DOI: https://doi.org/10.1590/s1413-35552012005000011

  21. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WC, Jackson A, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81-8. DOI: https://doi.org/10.1183/09031936.00104909

  22. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax. 2007;62(11):944-49. DOI: https://doi.org/10.1136/thx.2007.078980

  23. Wuthrich VM, Johnco CJ, Wetherell JL. Differences in anxiety and depression symptoms: comparison between older and younger clinical samples. Int Psychogeriatr. 2015;27(9):1523-32. DOI: https://doi.org/10.1017/S1041610215000526

  24. Betancourt-Peña J, Tonguino-Rosero S, Rosero-Carvajal HE, Hurtado H. Diferencias de la rehabilitación pulmonar en pacientes con EPOC, con y sin indicación de oxígeno domiciliario a largo plazo. Fisioterapia. 2018;40(4):169-77. DOI: https://doi.org/10.1016/j.ft.2018.03.005

  25. Al-Gamal E. Quality of life, anxiety and depression among patients with chronic obstructive pulmonary disease and their spouses. Issues Mentl Health Nur. 2014;35(10):761-7. DOI: https://doi.org/10.3109/01612840.2014.908440

  26. Smid DE, Franssen FM, Houben-Wilke S, Vanfleteren LE, Janssen DJ, Wouters EF, Spruit MA. Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J Am Med Dir Assoc. 2017;18(1):53-8. DOI: https://doi.org/10.1016/j.jamda.2016.08.002

  27. Sciriha A, Lungaro-Mifsud S, Scerri J, Magro R, Camilleri L, Montefort S. Health status of COPD patients undergoing pulmonary rehabilitation: A comparative responsiveness of the CAT and SGRQ. Chronic respiratory disease. 2017;14(4):352-59. DOI: https://dx.doi.org/10.1177/1479972317694622

  28. Vanleerberghe P, De Witte N, Claes C, Schalock RL, Verté D. The quality of life of older people aging in place: a literature review. Quality of Life Research. 2017;26(11):2899-907. DOI: https://doi.org/10.1007/s11136-017-1651-0

  29. Lee H, Jhun BW, Cho J, Yoo KH, Lee JH, Kim DK, et al. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity. Int J Chron Obstruct Pulmon Dis. 2017;12:3301-10. DOI: https://doi.org/10.2147/COPD.S145910

  30. Vaz-Fragoso CA., Enright PL, McAvay G, Van Ness PH, Gill TM. Frailty and respiratory impairment in older persons. American J Med. 2013;125(1):79-86. DOI: https://dx.doi.org/10.1016/j.amjmed.2011.06.024




2020     |     www.medigraphic.com